Message from the President: 2020 Virtual Meeting Updates

-

To the ISEH Community:

Dear friends and colleagues,

I hope that you all have remained well during these unprecedented times. Over the last few months, our international scientific community has faced concerns over funding, lab shut-downs and re-opening plans, staying connected to lab members and the broader scientific community, and more recently social unrest. In light of all of this, I am truly impressed with our ingenuity and dedication to staying connected and abreast of the latest science. New avenues to view and present our research stories have grown out of necessity in this pandemic. Now, more than ever, our members are seeking an inclusive community to share with and learn from one another.

In this spirit, I am excited to share some new details for our first Virtual ISEH 2020 Annual Scientific Meeting, which will take place on 19-21 August 2020.

Our three-day ISEH 2020 Annual Scientific Meeting will include live broadcasts twice daily to maximize opportunities for members around the world to view live sessions. Sessions will also be available on-demand for further view for a limited time following the meeting. It will feature:

  • Lectures from our 2020 Award Winners: Harvey Lodish (Donald Metcalf Award), Mark Dawson (McCulloch & Till Award), and Jennifer Trowbridge (Janet Rowley Award). You do not want to miss these lectures.
  •  Presentations and live Q&A from the top international hematology experts: Featuring plenary and selected abstract speakers from all career stages, as well as enhanced e-poster presentations. The Call for Abstracts is still open and will be extended to 25 June 2020.
  • Cutting-edge science: Unpublished scientific data is a hallmark of ISEH. We are taking every possible precaution to ensure that content is secure and to help our presenters feel comfortable sharing the latest and greatest science.
  • Enhanced networking: At ISEH, we’re excited to try out new virtual avenues for connection. Throughout the meeting, we will help you connect with colleagues via chat features, extended Q&A sessions, small meetings with speakers, and more.
  • Developing junior investigators: Support of junior investigators is a pillar of ISEH. We are proud to bring you many of our new investigator activities in 2020, including our career and technology sessions. Additionally, we hope to build in new opportunities for junior investigators to connect with senior scientists in the field, including an option for eligible abstract authors to select senior investigators in the society to view and provide feedback on their posters.

Registration for the virtual meeting is now open. You can learn more by visiting www.iseh.org/Virtual2020. With our dramatically reduced registration rates for 2020, we hope to provide an opportunity for students, young investigators, and senior scientists around the world to engage with us.

So no hesitations, book the time, register, submit an abstract, and we are much looking forward to seeing you all online in August.

Sincerely,




Emmanuelle Passegué
ISEH President


Comments

Post a Comment

Popular posts from this blog

Transition from academia to industry: An interview with Elizabeth Paik

-
Image
We have all read many articles about the possible career choices of a scientist. The usual dilemma is between industry and academia. We have talked about this in previous blogs but the more information we get the easier it is to make a wise choice. Of course we all have opinions about the pros and cons of such a choice but what I always find best is to ask people who have experienced both. That is why I turned to an old colleague and friend, Elizabeth Paik, and asked her some questions regarding her experiences in both academia and industry. Can you describe to us your scientific career? I started my career at Harvard Medical School, as a graduate student in Dr. Len Zon's laboratory. My thesis work focused on understanding a role of CDX transcription factors during embryonic hematopoiesis. Through ChIP-seq, knockdown and overexpression studies in zebrafish, I showed CDX transcription factors control expression of hematopoietic transcription factors - SCL and LMO2. Towards the...
Read more

ISEH 2024 Society Award Winners

-
Image
On behalf of the Awards Committee, ISEH would like to congratulate the recipients of the 2024 ISEH Society Awards which will be presented at the ISEH 53rd Annual Scientific Meeting . Donald Metcalf Award Winner - Emmanuelle Passegué The 2024 Donald Metcalf Award goes to Dr. Emmanuelle Passegué for her outstanding work in the fields of normal and malignant hematopoietic stem cell biology. Dr. Passegué, Alumni Professor of Genetics & Development and Director of the Columbia Stem Cell Initiative (CSCI) at Columbia University Irving Medical Center in New York city, receives the highest honor bestowed by the Society for her distinguished work as an outstanding scientist, leader, and role model.  Dr. Passegué grew up in France, and after PhD studies at the Collège de France in Paris she went on to postdoctoral research, first with Dr. Erwin Wagner at the Institute of Molecular Pathology in Vienna and with Dr. Irv. Weissman at Stanford University. In 2005, she started her own independ...
Read more

Lab Spotlight: Vanuytsel Lab

-
Image
  Each month, Simply Blood spotlights a lab contributing to the fields of hematology, immunology, stem cell research, cell and gene therapies, and more. Get to know groups doing cutting edge research from around the world! This month, we are featuring the Vanuytsel Lab which is based out of the Center for Regenerative Medicine, Boston University. How long has your lab been open and who is in your lab currently? The lab opened in July 2023 and currently consists of a lab manager, a PhD student, a postdoc and three undergraduate researchers. What is the overarching research goal for your group? Our lab studies concepts at the intersection of hematopoietic development, stem cell biology and sickle cell disease. We are trying to gain an in-depth understanding of engraftment potential and how that is orchestrated during development so that we can harness those insights to improve stem cell engraftment in the context of gene therapy and stem cell transplantations. What we learn from stu...
Read more